SCHEMBL1668540

SCHEMBL1668540

CS(=O)(=O)N1CCC(c2cc(F)c(OC3CN(Cc4ncc(C(F)(F)F)cn4)C3)c(F)c2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.39
RBP4 P02753 1/20 0.36
RORC P51449 1/20 0.36
KMT2A Q03164 2/20 0.36
LMNA P02545 1/20 0.36
NPY5R Q15761 1/20 0.35
CYP2D6 P10635 1/20 0.34
CYP3A4 P08684 2/20 0.34
MEN1 O00255 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
EPHX2 P34913 1/20 0.33
GPR119 Q8TDV5 3/20 0.33
PRMT5 O14744 2/20 0.33
MAP3K12 Q12852 1/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
NR1H2 P55055 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1668629 0.87 ADAMTS4 (0.37) IDO1RORCKMT2ALMNAGPR119
SCHEMBL1668410 0.85 KDM4E (0.49) RORCKMT2ALMNACYP2D6CYP3A4
SCHEMBL12198361 0.85 PDE9A (0.33)
SCHEMBL1669079 0.83 LMNA (0.38) IDO1RBP4RORCKMT2ALMNA
SCHEMBL1668617 0.81 KDM4E (0.41) IDO1RORCKMT2ALMNANPY5R
SCHEMBL1668609 0.80 FPR2 (0.37) IDO1RBP4RORCKMT2ALMNA
SCHEMBL12198265 0.80 KDM4E (0.41) IDO1RORCKMT2ALMNANPY5R
SCHEMBL1668262 0.80 KDM4E (0.48) RORCKMT2ALMNACYP2D6CYP3A4
SCHEMBL1669062 0.80 SCN8A (0.40) IDO1RORCKMT2ALMNANPY5R
SCHEMBL1668891 0.80 GPR119 (0.48) IDO1RORCKMT2ALMNANPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US claimed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP claimed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US claimed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO claimed
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US disclosed
US-8575168-B2 Compounds and compositions as modulators of GPR119 activity IRM LLC (BM) 2013-11-05 US disclosed
EP-2486033-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2012-08-15 EP disclosed
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-10-06 US disclosed
WO-2011044001-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY IRM LLC (BM) 2011-04-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245220-A1 COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY GPR119, GPR65, GPR39 IDO1 3041/4885RBP4 2021/4885RORC 361/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.